Use of a c-Met-targeting aptamer-drug conjugate for efficient therapy in both primary and metastatic uveal melanoma.
Uveal melanoma (UM), the most common primary intraocular malignancy in adults, is associated with a high risk of metastasis, recurrence, and irreversible vision loss. However, current therapeutic options remain limited by insufficient efficacy and poor vision preservation. Building upon the molecular design of SL1-MMAE...